While rapid positive advances in medical science roll out, global healthcare systems still face an important opportunity for transformation: a prevention healthcare revolution.
Wales has extended a scheme to harness the power of genomics to improve cancer care and prevention via an alliance with gene-sequencing giant Illumina.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.